Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
PETROCHINA
00857
No Data
Firebrick Pharma to Brief Investors After Nasodine Approval and $1.5m Placement
Firebrick Pharma Ramps up Nasodine Rollout and Global Push With New Capital and Hires
Firebrick Pharma Issues 6.38 Million Unquoted Options Expiring 2028
Firebrick Pharma Investor Goodall Sees Voting Power Diluted After Private Placement
Firebrick Pharma Private Placement Dilutes Major Shareholder's Voting Power
Firebrick Pharma Issues 1 Million Unlisted Employee Options